Skip to content

The influence of intelligent remote cardiac rehabilitation on the cardiopulmonary function and prognosis of patients with persistent atrial fibrillation

The influence of intelligent remote cardiac rehabilitation on the cardiopulmonary function and prognosis of patients with persistent atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113186
Enrollment
Unknown
Registered
2025-11-25
Start date
2025-11-26
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-paroxysmal atrial fibrillation

Interventions

Conventional treatment + cardiac rehabilitation + intelligent service group:Conventional Treatment Cardiac Rehabilitation Smart Service Group
Conventional treatment group:Conventional treatment
Conventional treatment + cardiac rehabilitation group:Conventional treatment+Cardiac rehabilitation exercise

Sponsors

Tianjin Fourth Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for persistent atrial fibrillation as stipulated in the "Chinese Guidelines for the Diagnosis and Treatment of Atrial Fibrillation", and be aged between 18 and 75 years old. 2.Be able to communicate normally with medical staff and be willing to accept cardiac rehabilitation treatment; The sports risk levels are classified as moderate risk and low risk. 3.Patients who can receive long-term and regular anticoagulant therapy (warfarin or new oral anticoagulants).

Exclusion criteria

Exclusion criteria: 1.Those who have a history of acute myocardial infarction within one month; 2.For patients with severe malignant arrhythmia and high-grade atrioventricular block without pacemaker treatment; 3.Those with concurrent malignant tumors; 4.Those with impaired functions of vital organs; 5.Uncontrolled hypertension (SBP greater than 200mmHg or DBP greater than 110mmHg); 6.Symptomatic hypertrophic obstructive cardiomyopathy or aortic stenosis; 7.Patients who underwent radiofrequency ablation during the enrollment period; 8.Those who have recently been classified as high-risk due to thromboembolism and exercise risk stratification; 9.Due to various reasons for loss of follow-up or expected survival time, the test criteria were dropped; 10.Patients who have undergone previous heart valve replacement or repair surgeries; 11.Those with a history of severe stroke, cerebral hemorrhage, serious mental illness, cognitive dysfunction or inability to communicate and cooperate; 12.Those who are unable to persist in cardiac rehabilitation training due to adverse events such as acute aggravation of the condition, concurrent other diseases, musculoskeletal events, etc; 13.Subjects may voluntarily decide to withdraw from the trial at any time.

Design outcomes

Primary

MeasureTime frame
Symptom assessment: Quality of Life Rating Scale (SF-36);Vital sign;6-Minute Walk Test;Cardiopulmonary Exercise Test;Serological test;Echocardiogram;

Secondary

MeasureTime frame
Psychological Assessment and Quality of Life Assessment;Hospitalization details;Compliance Assessment;Adverse Event Risk Assessment;

Countries

China

Contacts

Public ContactLingyu Kong

Tianjin Fourth Central Hospital

393183685@qq.com+86 22 2624 9387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026